Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

被引:774
作者
Du, Heng [2 ,3 ]
Guo, Lan [2 ,3 ]
Fang, Fang [2 ,3 ]
Chen, Doris [2 ,3 ]
Sosunov, Alexander A.
McKhann, Guy M.
Yan, Yilin [1 ]
Wang, Chunyu [1 ]
Zhang, Hong [4 ,5 ]
Molkentin, Jeffery D. [6 ]
Gunn-Moore, Frank J. [7 ]
Vonsattel, Jean Paul [4 ]
Arancio, Ottavio [4 ,5 ]
Chen, John Xi [8 ]
Du Yan, Shi [2 ,3 ,4 ,5 ]
机构
[1] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA
[2] Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA
[4] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[5] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[6] Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA
[7] Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland
[8] Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA
关键词
D O I
10.1038/nm.1868
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclophilin D (CypD, encoded by Ppif) is an integral part of the mitochondrial permeability transition pore, whose opening leads to cell death. Here we show that interaction of CypD with mitochondrial amyloid-beta protein (A beta) potentiates mitochondrial, neuronal and synaptic stress. The CypD-deficient cortical mitochondria are resistant to A beta- and Ca2+-induced mitochondrial swelling and permeability transition. Additionally, they have an increased calcium buffering capacity and generate fewer mitochondrial reactive oxygen species. Furthermore, the absence of CypD protects neurons from A beta- and oxidative stress-induced cell death. Notably, CypD deficiency substantially improves learning and memory and synaptic function in an Alzheimer's disease mouse model and alleviates A beta-mediated reduction of long-term potentiation. Thus, the CypD-mediated mitochondrial permeability transition pore is directly linked to the cellular and synaptic perturbations observed in the pathogenesis of Alzheimer's disease. Blockade of CypD may be a therapeutic strategy in Alzheimer's disease.
引用
收藏
页码:1097 / 1105
页数:9
相关论文
共 56 条
  • [21] Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice
    Esposito, Luke
    Raber, Jacob
    Kekonius, Lisa
    Yan, Fengrong
    Yu, Giu-Qiu
    Bien-Ly, Nga
    Puolivali, Jukka
    Scearce-Levie, Kimberly
    Masliah, Eliezer
    Mucke, Lennart
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (19) : 5167 - 5179
  • [22] Fernández-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823
  • [23] Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability
    Friberg, H
    Connern, C
    Halestrap, AP
    Wieloch, T
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) : 2488 - 2497
  • [24] Biochemistry - A pore way to die
    Halestrap, A
    [J]. NATURE, 2005, 434 (7033) : 578 - 579
  • [25] Calcium, mitochondria and reperfusion injury: a pore way to die
    Halestrap, AP
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 : 232 - 237
  • [26] Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase
    Halestrap, AP
    Woodfield, KY
    Connern, CP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) : 3346 - 3354
  • [27] The permeability transition pore complex: another view
    Halestrap, AP
    McStay, GP
    Clarke, SJ
    [J]. BIOCHIMIE, 2002, 84 (2-3) : 153 - 166
  • [28] A MODEL FOR BETA-AMYLOID AGGREGATION AND NEUROTOXICITY BASED ON FREE-RADICAL GENERATION BY THE PEPTIDE - RELEVANCE TO ALZHEIMER-DISEASE
    HENSLEY, K
    CARNEY, JM
    MATTSON, MP
    AKSENOVA, M
    HARRIS, M
    WU, JF
    FLOYD, RA
    BUTTERFIELD, DA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 3270 - 3274
  • [29] Mitochondrial abnormalities in Alzheimer's disease
    Hirai, K
    Aliev, G
    Nunomura, A
    Fujioka, H
    Russell, RL
    Atwood, CS
    Johnson, AB
    Kress, Y
    Vinters, HV
    Tabaton, M
    Shimohama, S
    Cash, AD
    Siedlak, SL
    Harris, PLR
    Jones, PK
    Petersen, RB
    Perry, G
    Smith, MA
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (09) : 3017 - 3023
  • [30] Hou FF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351296